Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00584428
What this trial is testing

High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
University of Oklahoma 61
Not applicableLooking for participantsNCT07214324
What this trial is testing

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 60
Early research (Phase 1)Study completedNCT00101179
What this trial is testing

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndrome+5 more
National Cancer Institute (NCI) 63
Not applicableNot Yet RecruitingNCT07717164
What this trial is testing

PRAISE-IR Versus CIBMTR Controls

Who this might be right for
ALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome)
Miltenyi Biomedicine GmbH 51
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00330421
What this trial is testing

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Who this might be right for
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorMetastatic OsteosarcomaRecurrent Adult Soft Tissue Sarcoma+6 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Not applicableNot Yet RecruitingNCT07341048
What this trial is testing

Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera

Who this might be right for
PolycythemiaPolycythemia Vera (PV)
Hospices Civils de Lyon 54
Testing effectiveness (Phase 2)Study completedNCT04067115
What this trial is testing

SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients

Who this might be right for
Ewing Sarcoma
Sarcoma Alliance for Research through Collaboration 37
Post-approval studies (Phase 4)Study completedNCT00688038
What this trial is testing

Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy

Who this might be right for
Advanced CancerBone Metastases
M.D. Anderson Cancer Center 24
Not applicableLooking for participantsNCT07325578
What this trial is testing

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

Who this might be right for
Bone TumorOsteoporosisTraumatic Fracture
Precision IO Group 60
Not applicableUnknownNCT03062436
What this trial is testing

To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission

Who this might be right for
Chronic Myeloid LeukemiaTreatment Free Remission
Command Hospital, India 27
Very early researchLooking for participantsNCT07628634
What this trial is testing

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Who this might be right for
AdenocarcinomaBasal Cell CarcinomaSquamous Cell Carcinoma+12 more
University of California, Irvine 25
Testing effectiveness (Phase 2)Ended earlyNCT02758132
What this trial is testing

Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases

Who this might be right for
Prostate Cancer
University of Hawaii 1
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Large-scale testing (Phase 3)UnknownNCT00303784
What this trial is testing

Prostate Adenocarcinoma TransCutaneous Hormones

Who this might be right for
AnemiaCardiovascular ComplicationsHot Flashes+2 more
University College, London 2,200
Not applicableStudy completedNCT00538109
What this trial is testing

An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Who this might be right for
Leukemia, Myeloid, Chronic
King Faisal Specialist Hospital & Research Center 8
Not applicableStudy completedNCT00136032
What this trial is testing

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

Who this might be right for
Growth Hormone Deficiency
Massachusetts General Hospital 63
Large-scale testing (Phase 3)Ended earlyNCT03408652
What this trial is testing

Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 1
Early research (Phase 1)Looking for participantsNCT06492954
What this trial is testing

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

Who this might be right for
OsteosarcomaPulmonary Recurrence of Osteosarcoma
Emory University 12
Next Page